
This ETF commits a minimum of 80% of its capital to mirroring the composition of its underlying index. The benchmark itself is carved out from a select portion of the broader Russell 1000 Index constituents. Its objective is to capture the returns of large and mid-sized American companies, spanning both growth and value investing styles, by applying a systematic, rule-driven investment methodology. While this process generally yields between 325 and 400 constituent stocks, the precise count is not fixed and can vary, as the index does not impose limits on the number of companies it holds.
Is RECS's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Columbia Research Enhanced Core ETF (NYSEARCA:RECS - Get Free Report)'s stock price reached a new 52-week high on Friday. The stock traded as high as $41.94 and last traded at $41.86, with a volume of 49467 shares trading hands. The stock had previously closed at $41.55. Columbia Research Enhanced Core ETF Stock Performance The

Ameriprise Financial Inc. boosted its holdings in shares of Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 1.8% during the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 13,203,009 shares of the company's stock after purchasing an additional 239,164 shares during the period. Ameriprise Financial Inc.

BlueStem Wealth Partners LLC lowered its position in Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 32.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 715,442 shares of the company's stock after selling 347,497 shares during the

Empirical Asset Management LLC lessened its holdings in Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 52.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,723 shares of the company's stock after selling 36,402 shares during the quarter. Empirical Asset Management

Atria Investments Inc increased its position in Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 9.9% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 209,020 shares of the company's stock after buying an additional 18,804 shares during the period. Atria Investments Inc owned about